Adani Ports on way to handling 400 MT cargo by 2025: CEO Karan Adani

The company, part of the globally diversified Adani Group which is the largest integrated logistics player in India, had achieved cargo throughput of 223MT in the last fiscal.

PTI

June 04, 2020 / 11:00 PM IST

live

bselive
nselive

Volume

Todays L/H

Adani Ports and Special Economic Zone (APSEZ), backed by steps like optimising operating processes to mitigate the impact of the coronavirus crisis, is on the path to achieving 400 million tonnes (MT) of cargo throughput by FY25, its Chief Executive Officer Karan Adani said.

The company, part of the globally diversified Adani Group which is the largest integrated logistics player in India, had achieved cargo throughput of 223MT in the last fiscal.

"Ready for the future crisis situations like what we are witnessing can be all consuming. Keeping this in mind, our focus has been on actions that will not compromise future sustainability or impact our ability to capture opportunities that almost always arise out of a crisis."

"We believe our actions will allow us to emerge stronger on the other side of the crisis and put us comfortably on the path to achieve 400MT of cargo by FY25 and thereby make progress towards becoming one of the most valuable port companies in the world by the end of the next decade," Adani said in the company's annual report released on Thursday.

He said in the company's crisis mitigation plans are also embedded specific plans that will allow it to strengthen teams, focus on financial management, build deeper customer relations, optimise operating processes, increase digitisation and most importantly maximise the goodwill of all stakeholders.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show